Journal Report

MULTIPLE SCLEROSIS AND RELATED DISORDERS

Download PDF
Journal Information
Journal Title
MULTIPLE SCLEROSIS AND RELATED DISORDERS
Publisher
ELSEVIER SCI LTD
ISSN
2211-0348
E-ISSN
2211-0356
Database
Clarivate
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Characterization of distinct cognitive domain patterns in AQP4-IgG-positive NMOSD: A MoCA-based factor analysis and risk profiling
Tingting Zhang, Yizuo Ma, Lai Wei et al.
2026-12 Vol. 116 Pages 108005
DOI: 10.1016/j.msard.2026.108005
Gut microbiome and physical activity in paediatric-onset multiple sclerosis
S. Stephens, T. Da Silva, F Zhu et al.
2026-12 Vol. 116 Pages 108023
DOI: 10.1016/j.msard.2026.108023
Latin American consensus recommendations on the role of magnetic resonance imaging in neuromyelitis optica spectrum disorder in clinical practice
Edgar Carnero Contentti, Juan I. Rojas, Jorge Correale et al.
2026-12 Vol. 116 Pages 108027
DOI: 10.1016/j.msard.2026.108027
Sudomotor dysfunction in multiple sclerosis: A systematic review and meta-analysis
Mašan Sredanović, Magdalena Krbot Skorić, Hana Rakuša et al.
2026-12 Vol. 116 Pages 108006
DOI: 10.1016/j.msard.2026.108006
Short term effect of repetitive transcranial magnetic stimulation of the medial sensorimotor cortex for neurogenic pelvic floor dysfunction in multiple sclerosis: a randomized, double blind, sham controlled trial
Ghaydaa A. Shehata, Gellan K. Ahmed, Yosra Abdallah Hassan et al.
2026-12 Vol. 116 Pages 108004
DOI: 10.1016/j.msard.2026.108004
Examining the effectiveness of theory-based nursing interventions for patients with multiple sclerosis (MS): A systematic review of randomized controlled trials
Aylin Meşe Tunç, Zeynep GENÇ Akgün, Gönül Gökçay et al.
2026-12 Vol. 116 Pages 107957
DOI: 10.1016/j.msard.2026.107957
Autoimmune comorbidity profiles in MOGAD and AQP4-NMOSD: a real-world evidence study of top 10 autoimmune disorders across the pre- and post-COVID-19 eras
Shou-Hui Chang, Chien-Heng Lin, Ru-Huei Fu et al.
2026-12 Vol. 116 Pages 108003
DOI: 10.1016/j.msard.2026.108003
The role of comorbidities in comprehensive healthcare utilization among people with multiple sclerosis
Lindsay O. Neto, Aaron P. Turner, Elizabeth S. Gromisch
2026-12 Vol. 116 Pages 108022
DOI: 10.1016/j.msard.2026.108022
Reduced perivascular diffusion in multiple sclerosis is associated with aging, disease duration, and mobility impairment
Sumire D. Sato, Sutton B. Richmond, Brett W. Fling et al.
2026-12 Vol. 116 Pages 107958
DOI: 10.1016/j.msard.2026.107958
Comment on “Lacosamide effects on pain management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial”
Antonio Alcántara Montero, Almudena Holguera Palacios
2026-12 Vol. 116 Pages 107990
DOI: 10.1016/j.msard.2026.107990
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 8, 2026 00:04